PSMi003-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg Name	PSMi003-A
Cell line type	Human induced pluripotent stem cell (hiPSC)
Last update	6th February 2018
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	IRCCS Policlinico San Matteo (PSM)
External Databases
Cellosaurus	CVCL_VE98
Wikidata	Q54948582
General Information
Publications	Mura M et al. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1. Stem cell research. 2018 May;29:170-173. (reference publication) Sala L et al. Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells. Arrhythmia & electrophysiology review. 2019 May;8(2):105-110. Wallace E et al. Long QT Syndrome: Genetics and Future Perspective. Pediatric cardiology. 2019 Oct;40(7):1419-1430. Goversen B et al. The influence of hERG1a and hERG1b isoforms on drug safety screening in iPSC-CMs. Progress in biophysics and molecular biology. 2019 Dec;149:86-98. Gnecchi M et al. Precision Medicine and cardiac channelopathies: when dreams meet reality. European heart journal. 2021 May 1;42(17):1661-1675. Song Y et al. Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Frontiers in cardiovascular medicine. 2022;9:889519. Lou J et al. Update on risk factors and biomarkers of sudden unexplained cardiac death. Journal of forensic and legal medicine. 2022 Apr;87:102332.

hIPSC Derivation

General